ARCHIVES

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

Report on Carcinogens: Advisors Recommend Tobacco, UV Light, Tamoxifen, For Report

November 7, 1997

Judah Folkman, Angiogenesis Pioneer, Dead at 74.

January 18, 2008

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

July 30, 2004

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

Behavior Scientists To Discuss Cancer Patient Rehabilitation

January 17, 1975

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

November 18, 2011